(Sharecast News) - In her 'Inside the City' column for the Sunday Times, Sabah Meddings described FTSE 100 pharmaceutical giant AstraZeneca as "riding high" for the last year, as a series of its drugs won approval from medicine regulators around the world.
Those included the cancer treatments Tagrisso, Calquence and Lynparza,...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE